CN1066337C - Specific drug for curing rheumatic arthritis and rheumatoid arthritis - Google Patents
Specific drug for curing rheumatic arthritis and rheumatoid arthritis Download PDFInfo
- Publication number
- CN1066337C CN1066337C CN97104088A CN97104088A CN1066337C CN 1066337 C CN1066337 C CN 1066337C CN 97104088 A CN97104088 A CN 97104088A CN 97104088 A CN97104088 A CN 97104088A CN 1066337 C CN1066337 C CN 1066337C
- Authority
- CN
- China
- Prior art keywords
- medicines
- medicine
- specific medicine
- powder
- rheumatoid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The present invention relates to a new specific medicine prepared from Chinese herbal medicines and used for curing rheumatic and rheumatoid osteoarthritis, which belongs to the technical field of Chinese base medicines. The specific medicine can effectively overcome the defects of the existing medicines in treatment. The specific medicine is mainly characterized in that the formula of the medicine uses silkworm, scorpion and pangolin for wind removal, spasmolysis, network vessel freeing and sputum elimination as main medicines and uses hinese ephedra, atractylodes rhizome, achyranthis bidentatae, licorice root, acanthopanax bark, frankincense and myrrh as auxiliary medicines. Firstly, the medicines are respectively processed, fine sprayed and placed in a container for sealing without air leakage. The medicine powder can be prepared into capsules, powder, medicinal granules, etc. The specific medicine is mainly used for curing rheumatic and rheumatoid osteoarthritis.
Description
The invention belongs to tcm field.
Prior art: rheumatism atrophic arthritis is a kind of common frdquently encountered disease, and treating primary disease at present mainly is to use rheumatism and rheumatoid Western medicine and most hormone medicine that cooperates to treat.Primary disease is used above western medicine majority in acute stage and can both be cured, but often not good to the therapeutic effect of chronic rheumatoid rheumatoid osteoarthritis, sends evil throughout one's life more.Prolonged application Western medicine person majority all has infringement to gastric mucosa, the generation granulocytopenia that has, the damage of the caused Liver and kidney that has, prolonged application hormone, the lighter causes edema, hypertension, myasthenia osteoporosis etc., and osteonecrosis (femur head necrosis person is work) can take place weight person.
Purpose of the present invention: be for a kind of specially good effect new drug for the treatment of the rheumatism and rheumatoid osteoarthritis is provided, it can effectively solve the existing shortcoming and defect of medicine in treatment.
Concrete scheme:
Side medicine Bombyx Batryticatus, Scorpio, Squama Manis, Cortex Acanthopancis, Olibanum, Myrrha, Herba Ephedrae, Rhizoma Atractylodis, Radix Glycyrrhizae, Radix Achyranthis Bidentatae.
Weight (%) 0-15 10-15 10-15 10-15 10-15 10-15 5-10 5-10 5-10 5-10 embodiment: Bombyx Batryticatus, Scorpio, Squama Manis, Cortex Acanthopancis, Olibanum, Myrrha, Herba Ephedrae, Rhizoma Atractylodis, Radix Glycyrrhizae, Radix Achyranthis Bidentatae.
Weight (gram) 20 20 20 20 20 20 15 15 15 15 15 15 15
Compound method: the Olibanum Myrrha is fried deoil Bombyx Batryticatus, Scorpio, Radix Glycyrrhizae, Rhizoma Atractylodis, Herba Ephedrae, Radix Achyranthis Bidentatae and is fried respectively to the crisp porphyrize foam altogether of Huang and cross the 40-100 mesh sieve, adorns that sealing does not make disappointing in the molten device.
Advantage of the present invention and good effect;
1. take this medicine for a long time, not only harmless to body, and can increase the resistance of body to various destructive stimuluses.And the merit of invigorating the liver and kidney promoting blood circulation to remove obstruction in the collateral bone and muscle strengthening arranged.
2. to the effective percentage 99% (except the allergy sufferers) of acute and chronic rheumatism and rheumatoid osteoarthritis, this medicine of continuous application reaches 3-4 month, can reach more than 95% the chronic patients cure rate.
Realize best way of the present invention;
This medicine is the oral medicine of treatment rheumatism and rheumatoid osteoarthritis.
Usage: service once every day sooner or later, takes after mixing it with water with yellow wine.
Consumption: usual amounts 0.8-1.0 gram/times 2 times/day
Maximum dose 1.5 gram/times 2 times/day
Child dose: per kilogram of body weight 25mg calculates by every day, divides 2 clothes sooner or later.
Old, chronic bronchitis, patients such as asthma, emphysema, heart disease, just clothes are used 1/2 of medicine always, add to common amount later on gradually, short of breath, palpitating speed can appear in the offender, limbs are shaken and feel nervous, phenomenon such as dizziness, but needn't fear, drinkable temperature tea or sweet mung bean soup one bowl of a moment i.e. mistake, does not have what danger.
Period in a medicine diet Semen phaseoli radiati, tea, raw meat are dizzy, raw and cold, do not have a cold.
Anemia of pregnant woman and autopath's forbidding.
Claims (2)
1, a kind of medicine for the treatment of rheumatism atrophic arthritis, it is characterized in that it is the powder of being made by the following raw material medicines in percentage by weight thing basically: Scorpio 10-15%, Squama Manis 10-15%, Cortex Acanthopancis 10-15%, Olibanum 10-15%, Myrrha 10-15%, Herba Ephedrae 10-15%, Rhizoma Atractylodis 10-15%, Radix Glycyrrhizae 10-15%, Radix Achyranthis Bidentatae 10-15%.
2, medicine according to claim 1 is characterized in that it also comprises Bombyx Batryticatus 0-15%.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN97104088A CN1066337C (en) | 1997-04-28 | 1997-04-28 | Specific drug for curing rheumatic arthritis and rheumatoid arthritis |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN97104088A CN1066337C (en) | 1997-04-28 | 1997-04-28 | Specific drug for curing rheumatic arthritis and rheumatoid arthritis |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1179956A CN1179956A (en) | 1998-04-29 |
CN1066337C true CN1066337C (en) | 2001-05-30 |
Family
ID=5167124
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN97104088A Expired - Fee Related CN1066337C (en) | 1997-04-28 | 1997-04-28 | Specific drug for curing rheumatic arthritis and rheumatoid arthritis |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN1066337C (en) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1092066C (en) * | 1999-12-27 | 2002-10-09 | 王振宇 | Analgesic plaster for osteoarthritis |
EP1301193A4 (en) * | 2000-07-19 | 2006-04-05 | Biodix Co Ltd | Process for preparing composition comprising medicinal herb extract for preventing and curing arthritis and composition thereof |
CN100348255C (en) * | 2005-06-03 | 2007-11-14 | 李伟阳 | Medication for treating ache of rheumatoid arthritis |
CN105044786B (en) * | 2015-05-14 | 2017-08-11 | 清华大学 | Pipe robot very low frequencies signal supervisory instrument based on quadrature coil sensor |
-
1997
- 1997-04-28 CN CN97104088A patent/CN1066337C/en not_active Expired - Fee Related
Non-Patent Citations (3)
Title |
---|
《中医要信息》1996,13(1) 1996.1.30 赵风书/通痹丸治疗类风湿性关节炎108例疗效观察 * |
《光明中医杂志》1995,(5) 1995.5.30 何兴锋/蚂蚁追风散治疗类风湿性关节炎90例 * |
《光明中医杂志》1995,(5) 1995.5.30 何兴锋/蚂蚁追风散治疗类风湿性关节炎90例;《中医要信息》1996,13(1) 1996.1.30 赵风书/通痹丸治疗类风湿性关节炎108例疗效观察 * |
Also Published As
Publication number | Publication date |
---|---|
CN1179956A (en) | 1998-04-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN100475250C (en) | An external use agent for treating chronic rhinitis and nasosinusitis | |
CN1843462A (en) | Medicine for treating necrosis of femoral head | |
CN1066337C (en) | Specific drug for curing rheumatic arthritis and rheumatoid arthritis | |
CN100336545C (en) | Medicinal wine with aizoon stonecrop for treating blood vessel disease and its preparation method | |
CN103638443A (en) | Traditional Chinese medicine for treating oesophagitis | |
CN100493549C (en) | Proprietary Chinese medicine for treating muscle and bone wound and rheumatism | |
CN100493554C (en) | Blood-activating kidney-tonifying pellet | |
CN105079444A (en) | Traditional Chinese medicine composition for treating bronchial asthma | |
CN102512528B (en) | Chinese medicinal composition for promoting osteoporotic fracture healing | |
CN103550715A (en) | Traditional Chinese medicine for treating bronchitis | |
CN1063960C (en) | Chinese medicine for treating hepatitis B | |
CN1422649A (en) | Chinese medicine proprietary for treating cerebrovascular and cardiovascular disease | |
CN1169542C (en) | Tonic wine for resisting rheumatism and rhematoid diseases | |
CN1235613C (en) | Medicine for promoting gastrointestinal function and its prepn process | |
CN1059594C (en) | Chinese medicine Gutongning and its preparation | |
CN101099812B (en) | Capsule for strengthening muscles and bones | |
CN1058612C (en) | Bixiling ointment and preparation thereof | |
CN1559496A (en) | Chinese medicine preparation of removing obstruction in the channels for treating atrophic arthritis | |
CN101953983B (en) | Chinese medicinal health wine for fortifying lumbus and freeing network vessels | |
CN101229359A (en) | Chinese traditional medicine compounds for treating abdomen distending pain, gastritis, gastric ulcer and preparing method thereof | |
CN1879808A (en) | A medicinal liquor for treating lesser yang meridian heat evil type cirrhosis and method for preparing same | |
CN105381415A (en) | Traditional Chinese medicine for treating rheumatoid arthritis | |
CN1879824A (en) | A medicinal liquor for treating damp-heat accumulation type liver cirrhosis and method for preparing same | |
CN104623611A (en) | Traditional Chinese medicine for treating stomach disease | |
CN101708322B (en) | Rheumatism-treating medicinal liquor |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
C19 | Lapse of patent right due to non-payment of the annual fee | ||
CF01 | Termination of patent right due to non-payment of annual fee |